ALIVE Israel HealthTech Fund

Co-founder who works closely with portfolio founders through results-focused, values-driven collaboration.

Co-founder who prioritizes investing in people and shaping corporate culture to align founders, management, and investors.

Professor and co-founder who believes HealthTech success comes from transforming deep technology into products that deliver clinical value for unmet needs.

Iris Beck is a certified global leadership coach and board director with over 20 years of executive experience at multinational organizations including Teva Pharmaceuticals, McCann Erickson Israel, Partner Orange Telecom, and Unilever. She holds an MBA and BA in Economics, both with distinction, and is a GLC Accredited Global Leadership Coach. Beck currently serves as Head of Corporate Venture Capital at Tidhar Real Estate Group and works with leaders and teams on executive coaching and organizational strategy.

Noy Hoffman is an Investment Associate at ALIVE Israel HealthTech Fund, focusing on growth-stage venture capital investments. He brings experience in product management, clinical execution, and healthtech investing, with operational exposure across Israel, the US, the UK, and India. At ALIVE VC, he supports investment processes and works with founders and healthtech leaders on growth acceleration.

Zeev Zehavi is Vice President of Venture Investments at Johnson & Johnson Innovation – JJDC, where he has held multiple roles since 1999, including European representative from 2007 to 2015 covering investments across pharmaceuticals, medical devices, and consumer health. Prior to joining JJDC, he spent over a decade at Teva Pharmaceutical Industries, serving as President of the bulk chemical business in North America, and subsequently led Clal Pharmaceutical Industries as President, overseeing private equity investments in generic R&D, drug delivery, and chiral chemistry. Zehavi holds a Bachelor of Science from Hebrew University of Jerusalem and an MBA in Marketing and Finance from Tel Aviv University, and currently serves as a Senior Advisor and Investment Committee member at the ALIVE Israel HealthTech Fund.